aluates Reports

$ 0.0

Automative

Global GLP-1 for Diabetes Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-21I12978

Global GLP 1 for Diabetes Market Research Report 2023

BUY CHAPTERS

Global GLP-1 for Diabetes Market Research Report 2024

Code: QYRE-Auto-21I12978

Report

May 2024

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GLP-1 for Diabetes Market Size

The global GLP-1 for Diabetes market was valued at US$ 20470 million in 2023 and is anticipated to reach US$ 40170 million by 2030, witnessing a CAGR of 9.6% during the forecast period 2024-2030.

GLP-1 for Diabetes Market

GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone in the body that plays a crucial role in glucose homeostasis. It is released from the intestine in response to food intake and stimulates the release of insulin from pancreatic beta cells. The primary function of insulin is to help cells in the body take up glucose, thereby lowering blood sugar levels.

Increasing Adoption of GLP-1 Receptor Agonists: GLP-1 receptor agonists were gaining popularity in the management of type 2 diabetes. These medications were recognized for their ability to improve glycemic control, stimulate insulin secretion, and offer potential benefits such as weight loss.

Development of New GLP-1 Therapies: Pharmaceutical companies were actively engaged in the research and development of new GLP-1 receptor agonists with improved formulations, longer durations of action, and enhanced patient adherence. This innovation aimed to provide more options for patients and healthcare providers.

Combination Therapies: The use of GLP-1 receptor agonists in combination with other classes of antidiabetic medications, such as SGLT-2 inhibitors or DPP-4 inhibitors, was explored to achieve better glycemic control and address multiple aspects of diabetes pathology.

Market Competition: The landscape for diabetes medications, including GLP-1 receptor agonists, was becoming more competitive. Competition often drives innovation and may lead to improved treatment options and cost-effectiveness.

This report aims to provide a comprehensive presentation of the global market for GLP-1 for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 for Diabetes.

Report Scope

The GLP-1 for Diabetes market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP-1 for Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GLP-1 for Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of GLP-1 for Diabetes Market Report

Report Metric	Details
Report Name	GLP-1 for Diabetes Market
Accounted market size in 2023	US$ 20470 million
Forecasted market size in 2030	US$ 40170 million
CAGR	9.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Injection Oral Agent
Segment by Application	Woman Man
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 for Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 for Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is GLP-1 for Diabetes Market growing?

Ans: The GLP-1 for Diabetes Market witnessing a CAGR of 9.6% during the forecast period 2024-2030.

What is the GLP-1 for Diabetes Market size in 2030?

Ans: The GLP-1 for Diabetes Market size in 2030 will be US$ 40170 million.

Who are the main players in the GLP-1 for Diabetes Market report?

Ans: The main players in the GLP-1 for Diabetes Market are Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin

What are the Application segmentation covered in the GLP-1 for Diabetes Market report?

Ans: The Applications covered in the GLP-1 for Diabetes Market report are Woman, Man

What are the Type segmentation covered in the GLP-1 for Diabetes Market report?

Ans: The Types covered in the GLP-1 for Diabetes Market report are Injection, Oral Agent

1 GLP-1 for Diabetes Market Overview

1.1 Product Overview and Scope of GLP-1 for Diabetes

1.2 GLP-1 for Diabetes Segment by Type

1.2.1 Global GLP-1 for Diabetes Market Value Comparison by Type (2024-2030)

1.2.2 Injection

1.2.3 Oral Agent

1.3 GLP-1 for Diabetes Segment by Application

1.3.1 Global GLP-1 for Diabetes Market Value by Application: (2024-2030)

1.3.2 Woman

1.3.3 Man

1.4 Global GLP-1 for Diabetes Market Size Estimates and Forecasts

1.4.1 Global GLP-1 for Diabetes Revenue 2019-2030

1.4.2 Global GLP-1 for Diabetes Sales 2019-2030

1.4.3 Global GLP-1 for Diabetes Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 GLP-1 for Diabetes Market Competition by Manufacturers

2.1 Global GLP-1 for Diabetes Sales Market Share by Manufacturers (2019-2024)

2.2 Global GLP-1 for Diabetes Revenue Market Share by Manufacturers (2019-2024)

2.3 Global GLP-1 for Diabetes Average Price by Manufacturers (2019-2024)

2.4 Global GLP-1 for Diabetes Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of GLP-1 for Diabetes, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of GLP-1 for Diabetes, Product Type & Application

2.7 GLP-1 for Diabetes Market Competitive Situation and Trends

2.7.1 GLP-1 for Diabetes Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest GLP-1 for Diabetes Players Market Share by Revenue

2.7.3 Global GLP-1 for Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 GLP-1 for Diabetes Retrospective Market Scenario by Region

3.1 Global GLP-1 for Diabetes Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global GLP-1 for Diabetes Global GLP-1 for Diabetes Sales by Region: 2019-2030

3.2.1 Global GLP-1 for Diabetes Sales by Region: 2019-2024

3.2.2 Global GLP-1 for Diabetes Sales by Region: 2025-2030

3.3 Global GLP-1 for Diabetes Global GLP-1 for Diabetes Revenue by Region: 2019-2030

3.3.1 Global GLP-1 for Diabetes Revenue by Region: 2019-2024

3.3.2 Global GLP-1 for Diabetes Revenue by Region: 2025-2030

3.4 North America GLP-1 for Diabetes Market Facts & Figures by Country

3.4.1 North America GLP-1 for Diabetes Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America GLP-1 for Diabetes Sales by Country (2019-2030)

3.4.3 North America GLP-1 for Diabetes Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe GLP-1 for Diabetes Market Facts & Figures by Country

3.5.1 Europe GLP-1 for Diabetes Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe GLP-1 for Diabetes Sales by Country (2019-2030)

3.5.3 Europe GLP-1 for Diabetes Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific GLP-1 for Diabetes Market Facts & Figures by Country

3.6.1 Asia Pacific GLP-1 for Diabetes Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific GLP-1 for Diabetes Sales by Country (2019-2030)

3.6.3 Asia Pacific GLP-1 for Diabetes Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America GLP-1 for Diabetes Market Facts & Figures by Country

3.7.1 Latin America GLP-1 for Diabetes Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America GLP-1 for Diabetes Sales by Country (2019-2030)

3.7.3 Latin America GLP-1 for Diabetes Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa GLP-1 for Diabetes Market Facts & Figures by Country

3.8.1 Middle East and Africa GLP-1 for Diabetes Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa GLP-1 for Diabetes Sales by Country (2019-2030)

3.8.3 Middle East and Africa GLP-1 for Diabetes Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global GLP-1 for Diabetes Sales by Type (2019-2030)

4.1.1 Global GLP-1 for Diabetes Sales by Type (2019-2024)

4.1.2 Global GLP-1 for Diabetes Sales by Type (2025-2030)

4.1.3 Global GLP-1 for Diabetes Sales Market Share by Type (2019-2030)

4.2 Global GLP-1 for Diabetes Revenue by Type (2019-2030)

4.2.1 Global GLP-1 for Diabetes Revenue by Type (2019-2024)

4.2.2 Global GLP-1 for Diabetes Revenue by Type (2025-2030)

4.2.3 Global GLP-1 for Diabetes Revenue Market Share by Type (2019-2030)

4.3 Global GLP-1 for Diabetes Price by Type (2019-2030)

5 Segment by Application

5.1 Global GLP-1 for Diabetes Sales by Application (2019-2030)

5.1.1 Global GLP-1 for Diabetes Sales by Application (2019-2024)

5.1.2 Global GLP-1 for Diabetes Sales by Application (2025-2030)

5.1.3 Global GLP-1 for Diabetes Sales Market Share by Application (2019-2030)

5.2 Global GLP-1 for Diabetes Revenue by Application (2019-2030)

5.2.1 Global GLP-1 for Diabetes Revenue by Application (2019-2024)

5.2.2 Global GLP-1 for Diabetes Revenue by Application (2025-2030)

5.2.3 Global GLP-1 for Diabetes Revenue Market Share by Application (2019-2030)

5.3 Global GLP-1 for Diabetes Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Corporation Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novo Nordisk GLP-1 for Diabetes Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca GLP-1 for Diabetes Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Eli Lily

6.3.1 Eli Lily Corporation Information

6.3.2 Eli Lily Description and Business Overview

6.3.3 Eli Lily GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Eli Lily GLP-1 for Diabetes Product Portfolio

6.3.5 Eli Lily Recent Developments/Updates

6.4 GSK

6.4.1 GSK Corporation Information

6.4.2 GSK Description and Business Overview

6.4.3 GSK GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GSK GLP-1 for Diabetes Product Portfolio

6.4.5 GSK Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Corporation Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sanofi GLP-1 for Diabetes Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Bristol-Myers Squibb

6.6.1 Bristol-Myers Squibb Corporation Information

6.6.2 Bristol-Myers Squibb Description and Business Overview

6.6.3 Bristol-Myers Squibb GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bristol-Myers Squibb GLP-1 for Diabetes Product Portfolio

6.6.5 Bristol-Myers Squibb Recent Developments/Updates

6.7 Amylin

6.6.1 Amylin Corporation Information

6.6.2 Amylin Description and Business Overview

6.6.3 Amylin GLP-1 for Diabetes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Amylin GLP-1 for Diabetes Product Portfolio

6.7.5 Amylin Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 GLP-1 for Diabetes Industry Chain Analysis

7.2 GLP-1 for Diabetes Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 GLP-1 for Diabetes Production Mode & Process

7.4 GLP-1 for Diabetes Sales and Marketing

7.4.1 GLP-1 for Diabetes Sales Channels

7.4.2 GLP-1 for Diabetes Distributors

7.5 GLP-1 for Diabetes Customers

8 GLP-1 for Diabetes Market Dynamics

8.1 GLP-1 for Diabetes Industry Trends

8.2 GLP-1 for Diabetes Market Drivers

8.3 GLP-1 for Diabetes Market Challenges

8.4 GLP-1 for Diabetes Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global GLP-1 for Diabetes Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global GLP-1 for Diabetes Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global GLP-1 for Diabetes Market Competitive Situation by Manufacturers in 2023

Table 4. Global GLP-1 for Diabetes Sales (Kg) of Key Manufacturers (2019-2024)

Table 5. Global GLP-1 for Diabetes Sales Market Share by Manufacturers (2019-2024)

Table 6. Global GLP-1 for Diabetes Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global GLP-1 for Diabetes Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market GLP-1 for Diabetes Average Price (US$/Mg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of GLP-1 for Diabetes, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of GLP-1 for Diabetes, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of GLP-1 for Diabetes, Product Type & Application

Table 12. Global Key Manufacturers of GLP-1 for Diabetes, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global GLP-1 for Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 for Diabetes as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global GLP-1 for Diabetes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global GLP-1 for Diabetes Sales by Region (2019-2024) & (Kg)

Table 18. Global GLP-1 for Diabetes Sales Market Share by Region (2019-2024)

Table 19. Global GLP-1 for Diabetes Sales by Region (2025-2030) & (Kg)

Table 20. Global GLP-1 for Diabetes Sales Market Share by Region (2025-2030)

Table 21. Global GLP-1 for Diabetes Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global GLP-1 for Diabetes Revenue Market Share by Region (2019-2024)

Table 23. Global GLP-1 for Diabetes Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global GLP-1 for Diabetes Revenue Market Share by Region (2025-2030)

Table 25. North America GLP-1 for Diabetes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America GLP-1 for Diabetes Sales by Country (2019-2024) & (Kg)

Table 27. North America GLP-1 for Diabetes Sales by Country (2025-2030) & (Kg)

Table 28. North America GLP-1 for Diabetes Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America GLP-1 for Diabetes Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe GLP-1 for Diabetes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe GLP-1 for Diabetes Sales by Country (2019-2024) & (Kg)

Table 32. Europe GLP-1 for Diabetes Sales by Country (2025-2030) & (Kg)

Table 33. Europe GLP-1 for Diabetes Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe GLP-1 for Diabetes Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific GLP-1 for Diabetes Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific GLP-1 for Diabetes Sales by Region (2019-2024) & (Kg)

Table 37. Asia Pacific GLP-1 for Diabetes Sales by Region (2025-2030) & (Kg)

Table 38. Asia Pacific GLP-1 for Diabetes Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific GLP-1 for Diabetes Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America GLP-1 for Diabetes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America GLP-1 for Diabetes Sales by Country (2019-2024) & (Kg)

Table 42. Latin America GLP-1 for Diabetes Sales by Country (2025-2030) & (Kg)

Table 43. Latin America GLP-1 for Diabetes Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America GLP-1 for Diabetes Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa GLP-1 for Diabetes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa GLP-1 for Diabetes Sales by Country (2019-2024) & (Kg)

Table 47. Middle East & Africa GLP-1 for Diabetes Sales by Country (2025-2030) & (Kg)

Table 48. Middle East & Africa GLP-1 for Diabetes Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa GLP-1 for Diabetes Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global GLP-1 for Diabetes Sales (Kg) by Type (2019-2024)

Table 51. Global GLP-1 for Diabetes Sales (Kg) by Type (2025-2030)

Table 52. Global GLP-1 for Diabetes Sales Market Share by Type (2019-2024)

Table 53. Global GLP-1 for Diabetes Sales Market Share by Type (2025-2030)

Table 54. Global GLP-1 for Diabetes Revenue (US$ Million) by Type (2019-2024)

Table 55. Global GLP-1 for Diabetes Revenue (US$ Million) by Type (2025-2030)

Table 56. Global GLP-1 for Diabetes Revenue Market Share by Type (2019-2024)

Table 57. Global GLP-1 for Diabetes Revenue Market Share by Type (2025-2030)

Table 58. Global GLP-1 for Diabetes Price (US$/Mg) by Type (2019-2024)

Table 59. Global GLP-1 for Diabetes Price (US$/Mg) by Type (2025-2030)

Table 60. Global GLP-1 for Diabetes Sales (Kg) by Application (2019-2024)

Table 61. Global GLP-1 for Diabetes Sales (Kg) by Application (2025-2030)

Table 62. Global GLP-1 for Diabetes Sales Market Share by Application (2019-2024)

Table 63. Global GLP-1 for Diabetes Sales Market Share by Application (2025-2030)

Table 64. Global GLP-1 for Diabetes Revenue (US$ Million) by Application (2019-2024)

Table 65. Global GLP-1 for Diabetes Revenue (US$ Million) by Application (2025-2030)

Table 66. Global GLP-1 for Diabetes Revenue Market Share by Application (2019-2024)

Table 67. Global GLP-1 for Diabetes Revenue Market Share by Application (2025-2030)

Table 68. Global GLP-1 for Diabetes Price (US$/Mg) by Application (2019-2024)

Table 69. Global GLP-1 for Diabetes Price (US$/Mg) by Application (2025-2030)

Table 70. Novo Nordisk Corporation Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 73. Novo Nordisk GLP-1 for Diabetes Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 78. AstraZeneca GLP-1 for Diabetes Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Eli Lily Corporation Information

Table 81. Eli Lily Description and Business Overview

Table 82. Eli Lily GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 83. Eli Lily GLP-1 for Diabetes Product

Table 84. Eli Lily Recent Developments/Updates

Table 85. GSK Corporation Information

Table 86. GSK Description and Business Overview

Table 87. GSK GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 88. GSK GLP-1 for Diabetes Product

Table 89. GSK Recent Developments/Updates

Table 90. Sanofi Corporation Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 93. Sanofi GLP-1 for Diabetes Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Bristol-Myers Squibb Corporation Information

Table 96. Bristol-Myers Squibb Description and Business Overview

Table 97. Bristol-Myers Squibb GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 98. Bristol-Myers Squibb GLP-1 for Diabetes Product

Table 99. Bristol-Myers Squibb Recent Developments/Updates

Table 100. Amylin Corporation Information

Table 101. Amylin Description and Business Overview

Table 102. Amylin GLP-1 for Diabetes Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)

Table 103. Amylin GLP-1 for Diabetes Product

Table 104. Amylin Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. GLP-1 for Diabetes Distributors List

Table 108. GLP-1 for Diabetes Customers List

Table 109. GLP-1 for Diabetes Market Trends

Table 110. GLP-1 for Diabetes Market Drivers

Table 111. GLP-1 for Diabetes Market Challenges

Table 112. GLP-1 for Diabetes Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of GLP-1 for Diabetes

Figure 2. Global GLP-1 for Diabetes Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global GLP-1 for Diabetes Market Share by Type in 2023 & 2030

Figure 4. Injection Product Picture

Figure 5. Oral Agent Product Picture

Figure 6. Global GLP-1 for Diabetes Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global GLP-1 for Diabetes Market Share by Application in 2023 & 2030

Figure 8. Woman

Figure 9. Man

Figure 10. Global GLP-1 for Diabetes Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global GLP-1 for Diabetes Market Size (2019-2030) & (US$ Million)

Figure 12. Global GLP-1 for Diabetes Sales (2019-2030) & (Kg)

Figure 13. Global GLP-1 for Diabetes Average Price (US$/Mg) & (2019-2030)

Figure 14. GLP-1 for Diabetes Report Years Considered

Figure 15. GLP-1 for Diabetes Sales Share by Manufacturers in 2023

Figure 16. Global GLP-1 for Diabetes Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest GLP-1 for Diabetes Players: Market Share by Revenue in 2023

Figure 18. GLP-1 for Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global GLP-1 for Diabetes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America GLP-1 for Diabetes Sales Market Share by Country (2019-2030)

Figure 21. North America GLP-1 for Diabetes Revenue Market Share by Country (2019-2030)

Figure 22. United States GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe GLP-1 for Diabetes Sales Market Share by Country (2019-2030)

Figure 25. Europe GLP-1 for Diabetes Revenue Market Share by Country (2019-2030)

Figure 26. Germany GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific GLP-1 for Diabetes Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific GLP-1 for Diabetes Revenue Market Share by Region (2019-2030)

Figure 33. China GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America GLP-1 for Diabetes Sales Market Share by Country (2019-2030)

Figure 41. Latin America GLP-1 for Diabetes Revenue Market Share by Country (2019-2030)

Figure 42. Mexico GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa GLP-1 for Diabetes Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa GLP-1 for Diabetes Revenue Market Share by Country (2019-2030)

Figure 48. Turkey GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE GLP-1 for Diabetes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of GLP-1 for Diabetes by Type (2019-2030)

Figure 52. Global Revenue Market Share of GLP-1 for Diabetes by Type (2019-2030)

Figure 53. Global GLP-1 for Diabetes Price (US$/Mg) by Type (2019-2030)

Figure 54. Global Sales Market Share of GLP-1 for Diabetes by Application (2019-2030)

Figure 55. Global Revenue Market Share of GLP-1 for Diabetes by Application (2019-2030)

Figure 56. Global GLP-1 for Diabetes Price (US$/Mg) by Application (2019-2030)

Figure 57. GLP-1 for Diabetes Value Chain

Figure 58. GLP-1 for Diabetes Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions